CC BY-NC-ND 4.0 · Aorta (Stamford) 2024; 12(02): 032-040
DOI: 10.1055/s-0044-1795130
Original Research Article

Experience with Zone 2 Arch Replacement Followed by Thoracic Endovascular Aortic Repair

1   Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington
,
Bret DeGraaff
1   Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington
,
Rachel Flodin
1   Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington
,
Anne Reimann-Moody
2   University of Washington School of Medicine, Seattle, Washington
,
2   University of Washington School of Medicine, Seattle, Washington
,
Sara Zettervall
3   Division of Vascular Surgery, University of Washington, Seattle, Washington
,
Sherene Shalhub
4   Division of Vascular Surgery, Oregon Health Sciences University, Portland, Oregon
,
Matthew P. Sweet
3   Division of Vascular Surgery, University of Washington, Seattle, Washington
,
Christopher R. Burke
1   Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington
,
Scott DeRoo
1   Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington
› Author Affiliations

Abstract

Background Transverse open aortic arch replacement remains a complex operation. A simplified arch replacement into zone 2, with debranching the head vessels proximally, creates a suitable landing zone for future endovascular repair and is increasing in popularity as of late. Still, limited data exist to assess contemporary rates of morbidity and mortality. Therefore, we aim to evaluate current outcomes for patients who underwent open zone 2 aortic arch replacement.

Methods All patients who underwent zone 2 arch replacement at a single academic institution from January 2019 to June 2023 were assessed. Indication for operation was either aneurysmal disease (n = 37), acute aortic syndrome (n = 38), or residual arch/descending thoracic aorta dissection (n = 67). Patient demographics and operative characteristics were evaluated, and the frequency of subsequent thoracic endovascular aortic repair (TEVAR) was noted. Mortality and major morbidity were then assessed.

Results A total of 142 patients underwent open zone 2 arch replacement. Median cardiopulmonary bypass, cross-clamp, and deep hypothermic circulatory arrest times for the entire cohort were 195, 122, and 36.5 minutes, respectively. Concomitant frozen elephant trunk was performed in 45.1% of the cohort (n = 64). In-hospital mortality was 7.8% (n = 11) for the entire cohort. Spinal cord ischemia occurred in 3.5% (n = 5); these patients all received frozen elephant trunks and had neurologic recovery by discharge. Stroke occurred in 9.2% (n = 13) of the study cohort. A total of 38.7% (n = 55) went on to get subsequent TEVAR, with median time to TEVAR of 52 days (8, 98.5).

Conclusion Zone 2 arch replacement allows staged repair of the thoracic aorta and readily accommodates future TEVAR therapy. This option for the treatment of the aortic arch can be performed safely in a wide variety of patient pathologies. Given the safety of this operation, cardiac surgeons should utilize this approach more frequently.



Publication History

Received: 16 October 2023

Accepted: 10 October 2024

Article published online:
26 November 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Jiang X, Liu Y, Zou L. et al. Long-term outcomes of chronic type B aortic dissection treated by thoracic endovascular aortic repair. J Am Heart Assoc 2023; 12 (01) e026914
  • 2 Conway AM, Qato K, Mondry LR, Stoffels GJ, Giangola G, Carroccio A. Outcomes of thoracic endovascular aortic repair for chronic aortic dissections. J Vasc Surg 2018; 67 (05) 1345-1352
  • 3 Ogawa Y, Watkins AC, Lingala B. et al. Improved midterm outcomes after endovascular repair of nontraumatic descending thoracic aortic rupture compared with open surgery. J Thorac Cardiovasc Surg 2021; 161 (06) 2004-2012
  • 4 Jubouri M, Bashir M, Tan SZCP. et al. What is the optimal timing for thoracic endovascular aortic repair in uncomplicated type B aortic dissection?. J Card Surg 2022; 37 (04) 993-1001
  • 5 Torrent DJ, McFarland GE, Wang G. et al. Timing of thoracic endovascular aortic repair for uncomplicated acute type B aortic dissection and the association with complications. J Vasc Surg 2021; 73 (03) 826-835
  • 6 Wang GJ, Jackson BM, Foley PJ. et al. National trends in admissions, repair, and mortality for thoracic aortic aneurysm and type B dissection in the National Inpatient Sample. J Vasc Surg 2018; 67 (06) 1649-1658
  • 7 Dhanekula AS, Sweet MP, Desai N, Burke CR. Aortic arch stenting: current strategies, new technologies and future directions. Heart 2021; 107 (15) 1199-1205
  • 8 Reynolds K, Fatima J. Optimal landing zone for TEVAR. Endovascular Today 2020; 19 (11) 60-63
  • 9 Lombardi JV, Hughes GC, Appoo JJ. et al. Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) reporting standards for type B aortic dissections. J Vasc Surg 2020; 71 (03) 723-747
  • 10 Eleshra A, Panuccio G, Spanos K, Rohlffs F, von Kodolitsch Y, Kölbel T. Safety and effectiveness of TEVAR in native proximal landing zone 2 for chronic type B aortic dissection in patients with genetic aortic syndrome. J Endovasc Ther 2022; 29 (05) 717-723
  • 11 Shalhub S, Eagle KA, Asch FM, LeMaire SA, Milewicz DM. GenTAC Investigators for the Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) Consortium. Endovascular thoracic aortic repair in confirmed or suspected genetically triggered thoracic aortic dissection. J Vasc Surg 2018; 68 (02) 364-371
  • 12 Qato K, Conway A, Lu E, Tran NN, Giangola G, Carroccio A. Outcomes of thoracic endovascular aneurysm repair (TEVAR) in patients with connective tissue disorders. Vasc Endovascular Surg 2020; 54 (08) 676-680
  • 13 LeMaire SA, Price MD, Parenti JL. et al. Early outcomes after aortic arch replacement by using the Y-graft technique. Ann Thorac Surg 2011; 91 (03) 700-707 , discussion 707–708
  • 14 Settepani F, Cappai A, Basciu A, Barbone A, Tarelli G. Outcome of open total arch replacement in the modern era. J Vasc Surg 2016; 63 (02) 537-545
  • 15 Minatoya K, Inoue Y, Sasaki H. et al. Total arch replacement using a 4-branched graft with antegrade cerebral perfusion. J Thorac Cardiovasc Surg 2019; 157 (04) 1370-1378
  • 16 Patel HJ, Nguyen C, Diener AC, Passow MC, Salata D, Deeb GM. Open arch reconstruction in the endovascular era: analysis of 721 patients over 17 years. J Thorac Cardiovasc Surg 2011; 141 (06) 1417-1423
  • 17 Tian DH, Ha H, Joshi Y, Yan TD. Long-term outcomes of the frozen elephant trunk procedure: a systematic review. Ann Cardiothorac Surg 2020; 9 (03) 144-151
  • 18 Geragotellis A, Jubouri M, Hussain K. et al. Head-to-head: Zone 2 vs. Zone 3 frozen elephant trunk. Vessel Plus 2023; 7: 6
  • 19 Desai ND, Hoedt A, Wang G. et al. Simplifying aortic arch surgery: open zone 2 arch with single branched thoracic endovascular aortic repair completion. Ann Cardiothorac Surg 2018; 7 (03) 351-356
  • 20 Adeniyi A, Takayama H, Wu A. Assessing cardiovascular surgical outcomes in hemiarch, total arch, & zone 2 aortic replacements: a single-center experience. Poster presented at: 2020 Global and Population Health Student Projects Symposium; 2020 ; New York, NY.
  • 21 Dietze Z, Kang J, Madomegov K. et al. Aortic arch redo surgery: early and mid-term outcomes in 120 patients. Eur J Cardiothorac Surg 2023; 64 (06) ezad419
  • 22 Abt BG, Bojko M, Elsayed RS. et al. Branch-first aortic arch replacement strategy decreases perioperative mortality. J Thorac Cardiovasc Surg 2024; 167 (06) 2005-2012.e1
  • 23 van Bakel TM, de Beaufort HW, Trimarchi S. et al. Status of branched endovascular aortic arch repair. Ann Cardiothorac Surg 2018; 7 (03) 406-413
  • 24 Squiers JJ, DiMaio JM, Schaffer JM. et al. Surgical debranching versus branched endografting in zone 2 thoracic endovascular aortic repair. J Vasc Surg 2022; 75 (06) 1829-1836.e3
  • 25 Bavaria J, Vallabhajosyula P, Moeller P, Szeto W, Desai N, Pochettino A. Hybrid approaches in the treatment of aortic arch aneurysms: postoperative and midterm outcomes. J Thorac Cardiovasc Surg 2013; 145 (03) S85-S90
  • 26 Roselli EE, Vargo PR, Bakaeen F. et al; B-SAFER Investigators. Branched stented anastomosis frozen elephant trunk repair: early results from a physician-sponsored investigational device exemption study. J Thorac Cardiovasc Surg 2024; 168 (03) 746-756
  • 27 Pichlmaier M, Luehr M, Rutkowski S. et al. Aortic arch hybrid repair: stent-bridging of the supra-aortic vessel anastomoses (SAVSTEB). Ann Thorac Surg 2017; 104 (06) e463-e465
  • 28 Grabenwöger M, Mach M, Mächler H. et al. Taking the frozen elephant trunk technique to the next level by a stented side branch for a left subclavian artery connection: a feasibility study. Eur J Cardiothorac Surg 2021; 59 (06) 1247-1254
  • 29 Pichlmaier M, Tsilimparis N, Hagl C, Peterss S. New anatomical frozen elephant trunk graft for zone 0: endovascular technology reduces invasiveness of open surgery to the max. Eur J Cardiothorac Surg 2022; 61 (02) 490-492
  • 30 Zamor KC, Eskandari MK, Rodriguez HE, Ho KJ, Morasch MD, Hoel AW. Outcomes of thoracic endovascular aortic repair and subclavian revascularization techniques. J Am Coll Surg 2015; 221 (01) 93-100
  • 31 Voigt SL, Bishawi M, Ranney D, Yerokun B, McCann RL, Hughes GC. Outcomes of carotid-subclavian bypass performed in the setting of thoracic endovascular aortic repair. J Vasc Surg 2019; 69 (03) 701-709